Long-term Follow-up of antithrombotIc Management Patterns in Acute Coronary Syndrome Patients in Asia-China Extension

Evaluation on the Safety of Ticagrelor Among Chinese ACS Patients

NCT02430493 ·Status: COMPLETED

Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome

NCT01952392 ·Status: COMPLETED

Optimized Antiplatelet Therapy on the Prognosis of ACS Patients With Non-predominant Coronary Artery Disease After PCI

NCT04338919 ·Status: UNKNOWN ·Phase: NA

A Study of Low and Standard-dose Ticagrelor After Intervention for ACS Patients

NCT04255602 ·Status: RECRUITING ·Phase: PHASE4

Study of Artery Conditions of 'At-risk' Asian People Not on Lipid-lowering Drugs

NCT00970918 ·Status: COMPLETED ·Phase: NA

Thromboxane B2 and Platelet Function Testing as Measures of Aspirin Resistance in Hong Kong Chinese Patients

NCT04863053 ·Status: COMPLETED

AZD5718 Phase IIa Study to Evaluate Efficacy, Safety and Tolerability of Oral AZD5718 in Patients With Coronary Artery Disease (CAD).

NCT03317002 ·Status: COMPLETED ·Phase: PHASE2

Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention

NCT04240834 ·Status: RECRUITING ·Phase: PHASE4

RuSsian RegisTry of Acute CoronaRy SyndromE TreAtMent and Approach in Dual Antiplatelet Therapy

NCT02288260 ·Status: COMPLETED

Study on Tirofiban With Aspirin in the Treatment of Acute Penetrating Artery Territory Infarction

NCT05310968 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization

NCT05347069 ·Status: RECRUITING ·Phase: PHASE4

Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4)

NCT03234114 ·Status: UNKNOWN ·Phase: PHASE4

Outcomes in UK ACS Patients Prescribed Ticagrelor

NCT03058601 ·Status: COMPLETED

Reversal of the Anti-platelet Effects of Ticagrelor

NCT02383771 ·Status: COMPLETED ·Phase: PHASE4

Effect of Indobufen and Aspirin on Platelet Aggregation and Long Term Prognosis in Patients With Coronary Heart Disease

NCT04308551 ·Status: WITHDRAWN ·Phase: NA

Aspirin Treatment for Small Unruptured InTracranial Aneurysms With Ischemic cereBrovascuLar diseasE

NCT05907902 ·Status: UNKNOWN ·Phase: PHASE3

A Study to Collect Data on the Treatment Pattern of Xarelto + Acetylsalicylic Acid in the Routine Clinical Practice in Patients Who Are Suffering From a Condition That Narrows the Blood Vessels Supplying the Heart and / or a Condition That Most Commonly Narrows the Blood Vessel in the Legs

NCT04401761 ·Status: COMPLETED

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese Subjects

NCT04588727 ·Status: COMPLETED ·Phase: PHASE1

Ticagrelor Monotherapy Compared to Aspirin Monotherapy in Patients With History of ACS

NCT03881943 ·Status: COMPLETED ·Phase: PHASE4

Aspirin Resistance and Percutaneous Coronary Intervention (PCI)

NCT01103440 ·Status: COMPLETED ·Phase: PHASE2

Platelet Function in Patients With an Acute Coronary Syndrome

NCT01992484 ·Status: UNKNOWN

Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event

NCT01395550 ·Status: COMPLETED

A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome

NCT02293395 ·Status: COMPLETED ·Phase: PHASE2

Direct Oral Anticoagulants in Patients With Atrial Fibrillation (DOACs vs DOACs)

NCT03568916 ·Status: COMPLETED

Impact of Evolocumab on the Antiplatelet Effects of Ticagrelor and Aspirin in Patients With Acute Coronary Syndrome

NCT05418166 ·Status: UNKNOWN